Chronic pain following treatment for cancer: The role of opioids

被引:46
作者
Ballantyne, JC
机构
[1] Massachusetts Gen Hosp, Pain Ctr, Dept Anesthesia & Crit Care, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
narcotics; pain; neoplasms; opioid-related disorders;
D O I
10.1634/theoncologist.8-6-567
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Opioids are the most effective analgesics for severe pain and the mainstay of acute and terminal cancer pain treatments. In those settings, opioids are used over a limited time period so that opioid tolerance, if it develops, is relatively easy to overcome, and other problems of opioid use, including substance abuse, are unlikely to be problematic. As cancer treatments improve and increasing numbers of cancer patients experience long remissions, chronic pain due to cancer, or to cancer treatment, becomes a clinical problem that oncologists will encounter. Chronic pain differs from acute and terminal pain in several fundamental respects. In the case of chronic pain, functional restoration is a predominant goal of treatment. Because it is often due to neuronal damage, the pain may be particularly sensitive to nonopioid medications, and opioids can be reserved for refractory pain. If opioids are chosen, tolerance, dependence, and addiction can interfere, and safeguards designed to minimize these must be built into the treatment plan. This article reviews the principles of chronic opioid therapy for non-cancer pain and how these principles may be adapted for patients with chronic pain due to cancer.
引用
收藏
页码:567 / 575
页数:9
相关论文
共 59 条
[1]   Endocrine consequences of long-term intrathecal administration of opioids [J].
Abs, R ;
Verhelst, J ;
Maeyaert, J ;
Van Buyten, JP ;
Opsomer, F ;
Adriaensen, H ;
Verlooy, J ;
Van Havenbergh, T ;
Smet, M ;
Van Acker, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (06) :2215-2222
[2]  
[Anonymous], WHO TECH REP SER
[3]  
[Anonymous], ANALGESIA
[4]  
BRODNER RA, 1978, MT SINAI J MED, V45, P233
[5]   THE COGNITIVE EFFECTS OF THE ADMINISTRATION OF NARCOTIC ANALGESICS IN PATIENTS WITH CANCER PAIN [J].
BRUERA, E ;
MACMILLAN, K ;
HANSON, J ;
MACDONALD, RN .
PAIN, 1989, 39 (01) :13-16
[6]  
Bruera E, 1996, CANCER, V78, P852, DOI 10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO
[7]  
2-T
[8]   An international survey of cancer pain characteristics and syndromes [J].
Caraceni, A ;
Portenoy, RK .
PAIN, 1999, 82 (03) :263-274
[9]   Strategies to manage the adverse effects of oral morphine: An evidence-based report [J].
Cherny, N ;
Ripamonti, C ;
Pereira, J ;
Davis, C ;
Fallon, M ;
McQuay, H ;
Mercadante, S ;
Pasternak, G ;
Ventafridda, V .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) :2542-2554
[10]  
CHERNY NJ, 1995, CANCER-AM CANCER SOC, V76, P1283, DOI 10.1002/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO